Guangping Gao

Active 1985–2025

216
Papers
32,050
Citations
94
h-index
201
i10-index

Citations

Citations per year for Guangping Gao1985: 6 citations1986: 6 citations1987: 1 citations1988: 2 citations1989: 3 citations1990: 1 citations1991: 3 citations1992: 3 citations1993: 1 citations1995: 1 citations1996: 1 citations1997: 9 citations1998: 17 citations1999: 35 citations2000: 67 citations2001: 69 citations2002: 122 citations2003: 180 citations2004: 195 citations2005: 285 citations2006: 260 citations2007: 195 citations2008: 223 citations2009: 212 citations2010: 168 citations2011: 222 citations2012: 154 citations2013: 176 citations2014: 191 citations2015: 163 citations2016: 199 citations2017: 276 citations2018: 266 citations2019: 902 citations2020: 1,063 citations2021: 1,265 citations2022: 1,251 citations2023: 1,221 citations2024: 1,966 citations2025: 1,191 citations2026: 37 citations1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,241 citing papers, 34.7% of this breakdownChina: 1,757 citing papers, 14.4% of this breakdownUnited Kingdom: 675 citing papers, 5.5% of this breakdownGermany: 622 citing papers, 5.1% of this breakdownFrance: 386 citing papers, 3.2% of this breakdownCanada: 360 citing papers, 3% of this breakdownItaly: 342 citing papers, 2.8% of this breakdownJapan: 309 citing papers, 2.5% of this breakdownAustralia: 274 citing papers, 2.2% of this breakdownNetherlands: 266 citing papers, 2.2% of this breakdownIndia: 250 citing papers, 2% of this breakdownSwitzerland: 215 citing papers, 1.8% of this breakdown
0%34.7%Other 20.6%

Fields

  • Biochemistry, Genetics and Molecular Biology63.8%
  • Medicine22.8%
  • Neuroscience6.1%
  • Immunology and Microbiology3.5%
  • Engineering1%
  • Materials Science0.7%
  • Other2.1%

Topics

  • Virus-based gene therapy research12.4%
  • CRISPR and Genetic Engineering8.4%
  • RNA Interference and Gene Delivery7.3%
  • Viral Infectious Diseases and Gene Expression in Insects3.2%
  • CAR-T cell therapy research3%
  • Advanced biosensing and bioanalysis techniques2.3%
  • Other63.4%

Coauthors

All papers

Open in search
  1. Adeno-associated virus vector as a platform for gene therapy delivery

    Authors: , , - Nature Reviews Drug Discovery 2019 cited by 2,387

  2. Viral vector platforms within the gene therapy landscape

    Authors: , , , , - Signal Transduction and Targeted Therapy 2021 cited by 1,311

  3. Adeno-associated virus as a delivery vector for gene therapy of human diseases

    Authors: , , , , - Signal Transduction and Targeted Therapy 2024 cited by 718

  4. Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2022 cited by 429

  5. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

    Authors: , , , , , , , , , - Nature Biotechnology 2023 cited by 274

  6. CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors

    Authors: , , - Cell 2020 cited by 535

  7. Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease

    Authors: , , , , , , , , , , , , - Immunity 2019 cited by 452

  8. Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses

    Authors: , , , , - The Journal of Infectious Diseases 2009 cited by 792

  9. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective

    Authors: , , , , , , , , , , , , , - Molecular Therapy 2022 cited by 193

  10. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2016 cited by 871

  11. Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues

    Authors: , , , , , , - Journal of Virology 2004 cited by 1,064

  12. Overcoming innate immune barriers that impede AAV gene therapy vectors

    Authors: , , , , , , - Journal of Clinical Investigation 2021 cited by 209

  13. Base editing rescue of spinal muscular atrophy in cells and in mice

    Authors: , , , , , , , , , , , , , , , , - Science 2023 cited by 135

  14. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

    Authors: , , , , , , , - Molecular Genetics and Metabolism 2003 cited by 1,465

  15. Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew J. Pezone, Ru Xiao, Tina Liu, Wei Wang, Henry J. Kaplan, Guangping Gao, Andrew D. Dick, Federico Mingozzi, Maureen A. McCall, Constance L. Cepko, George M. Church - Science Translational Medicine 2021 cited by 207

  16. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis

    Authors: , , , , , , , , , , , , , - Nature Communications 2017 cited by 327

  17. AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice

    Authors: , , , , , , , , , , , , , , - Nature 2022 cited by 135

  18. Durability of transgene expression after rAAV gene therapy

    Authors: , , , , - Molecular Therapy 2022 cited by 131

  19. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 116

  20. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 1,509

  21. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis

    Authors: , , , , , , , - Nature Communications 2019 cited by 141

  22. Dynamics of a disinhibitory prefrontal microcircuit in controlling social competition

    Authors: , , , , , , , , , , , , , - Neuron 2021 cited by 119

  23. Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects

    Authors: , , , , , , , , , , - Molecular Therapy — Methods & Clinical Development 2014 cited by 165

  24. Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manish Muhuri, Karen Kelly, Fiachra Humphries, Alyssa Cousineau, Krishna Mohan Parsi, Qi Li, Yang Wang, René Maehr, Guangping Gao, Dmitry Korkin, William M. McDougall, Robert W. Finberg, Katherine A. Fitzgerald, Jennifer Wang, Jonathan K. Watts, Anastasia Khvorova - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 48